Impact of Diabetes Prevalence on Endocrine Testing Market Growth Driver: Leading Transformation in the Endocrine Testing Market in 2025

"What Are the Projected Growth and Market Size Trends for the Endocrine Testing Market?
In the past few years, the endocrine testing market has seen a significant expansion. The market, which is worth $2.55 billion in 2024, is projected to reach $2.8 billion in the following year, growing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the historic period include the discovery of hormones and endocrine pathways, standardization of diagnostic tests, public health campaigns, and the empowerment of patients.

It is anticipated that the endocrine testing market will experience robust growth over the coming years, projected to reach $4.01 billion by 2029, with a compound annual growth rate (CAGR) of 9.5%. The anticipated growth in this timeframe is due to the rising incidence of endocrine disorders, enhanced defense expenditures, an aging demographic, improved awareness and early detection, and increased public knowledge. Key trends that are expected during this forecast period include progress in biomarker detection, the inclusion of omics technologies, applications of artificial intelligence and machine learning, assurance of quality and standardization, as well as joint research and translational medicine.

What Factors Are Fueling Growth in the Endocrine Testing Market?
The increasing occurrence of diabetes is anticipated to drive the expansion of the endocrine testing market. Diabetes constitutes a series of ailments that lead to elevated blood sugar levels. Factors contributing to a heightened incidence of diabetes include poor dietary habits, a lack of physical activity, genetic predisposition, and an aging demographic. Various forms of endocrine tests, such as hemoglobin A1c, fasting plasma glucose, and C-peptide tests, are utilized to diagnose, manage glucose levels, and determine insulin production and sensitivity in diabetes. As an example, in June 2024, the National Health Service (NHS), a government department from the UK, reported a rise in diabetes among people under 40, increasing from 173,166 in 2022 to 216,440 in 2023. This marked increase points out an alarming trend within this demographic. The information indicates a quick increase in diabetes among younger groups. Consequently, the escalating incidence of diabetes is fuelling the growth of the endocrine testing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

Which Leading Companies Are Shaping the Growth of the Endocrine Testing Market?
Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

What Are the Major Trends Shaping the Endocrine Testing Market?
Leading firms in the endocrine testing market are concentrating on the creation of point-of-care testing solutions to improve the speed and effectiveness of endocrine disorder diagnosis. The swift results facilitated by point-of-care testing can contribute to the timely diagnosis and treatment of patients exhibiting symptoms like fatigue and breathlessness from heart failure. For instance, in India, Roche Holding AG, a Swiss pharmaceutical firm, introduced a point-of-care NT-proBNP test specifically aimed at diabetic patients susceptible to cardiovascular diseases like heart failure in April 2024. The test allows for the quick detection and ensuing intervention, empowering medical practitioners to identify T2D patients in high-risk categories and kickstart beneficial treatment conversations. Ultimately, such measures lead to enhanced patient outcomes and improved health conditions.

What Are the Key Segments of the Endocrine Testing Market?
The endocrine testing market covered in this report is segmented -

1) By Test Type: Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types
2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users

Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test, Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test
10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

Which Region Dominates the Endocrine Testing Market?
North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Endocrine Testing Global Market Report?

- Market Size Analysis: Analyze the Endocrine Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Endocrine Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Endocrine Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Endocrine Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15562

"

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.